baber/WOPTO huggingface dataset:
Patent EP-3498057-A1 (EP)
Title: Procédé de remplacement d'unité d'éclairage
Inventor: LEYDECKER STEPHEN HAIGHT
IPC: H05B37/03
Filed: 2017-08-10
Abstract: L'invention porte sur un procédé de remplacement d'un module de lumière et/ou d'un module de pilote d'une unité d'éclairage, le module de lumière et le module de pilote comprenant chacun une mémoire de stockage de données, et sur une communication de lumière visuelle, VLC, dont le code a été stocké dans la mémoire de stockage de données du module de lumière et/ou dans la mémoire de stockage de données du module de pilote. Le module de commande est conçu pour commander le module de lumière de façon à émettre optiquement, par une modulation d'une sortie de lumière du module de lumière, des informations basées sur le code de VLC. Le procédé consiste à : a) lire le code de VLC dans la mémoire de stockage de données du module de lumière et dans la mémoire de stockage de données du module de pilote; b) transférer le code de VLC via une connexion entre le module de lumière et le module de pilote; c) stocker le code de VLC transféré dans l'autre module, le module de lumière et/ou le module de pilote; d) choisir le module de lumière et/ou le module de pilote en vue d'un remplacement; e) remplacer le module de lumière et/ou le module de pilote choisi pour le remplacement; et f) transférer le code de VLC de l'autre module de lumière et/ou de l'autre module de pilote au module de lumière et/ou au module de pilote remplacé(s), et g) stocker le code de VLC transféré dans la mémoire de stockage de données du module de lumière et/ou du module de pilote remplacé(s).
Patent EP-3421992-A1 (EP)
Inventor: LEE DONG YOUNG
IPC: G01N33/49
Filed: 2017-02-23
Abstract: The present disclosure relates to a culturing patch, culturing method, culture test method, culture test device, drug test method, and drug test device, and the culturing patch according to an aspect of the present disclosure includes component required for growth of an object to be cultured, and a mesh structural body provided in a mesh structure forming micro-cavities in which the component required for growth are contained that is configured to come into contact with a reaction region in which the object to be cultured is placed and provide some of the contained component required for growth to the reaction region.
Patent EP-3548102-A1 (EP)
Inventor: STIBICH MARK
IPC: A61L2/26
Filed: 2017-08-09
Abstract: Methods are provided that include positioning a disinfection apparatus in proximity to a cabinet, wherein the disinfection apparatus has a base supporting a germicidal source and the base includes components operationally coupled to the germicidal source for operating the germicidal source. The method further includes inserting the germicidal source into the cabinet such that at least a portion of the base is retained exterior to the cabinet and is operationally coupled to the germicidal source. Moreover, the method includes placing one or more items into the cabinet, closing the cabinet with the germicidal source and the one or more items in the cabinet and the base of the disinfection apparatus exterior to the cabinet, and then subsequently starting the disinfection source such that the germicidal source emits a germicide into the cabinet. Systems and cabinets used to conduct the aforementioned methods are also provided.
Patent EP-3425481-A1 (EP)
Inventor: OKUMURA YASUSHI
IPC: A63F13/42
Filed: 2017-02-09
Abstract: A control apparatus is connected to a device (20) for detecting a user's hand motion and controls a motion of a virtual character. The control apparatus decides, in accordance with a detection result of the user's hand motion by the device (20), whether the detected user's motion is a first instruction action or a second instruction action. The first instruction action achieves a match between a hand motion of the character and the user's hand motion. The second instruction action instructs an action different from the user's hand motion. When it is decided, as a result of the decision, that the detected user's hand motion is the first instruction action, the control apparatus achieves a match between the character's hand motion and the detected user's hand motion. When it is decided that the detected user's hand motion is the second instruction action, the control apparatus causes the character to perform an action different from the hand motion.
Patent EP-3423110-A1 (EP)
Inventor: KOTIN ROBERT M
IPC: C12N15/66
Filed: 2017-03-03
Abstract: Des aspects de la présente invention concernent un acide nucléique comprenant un insert d'acide nucléique hétérologue flanqué par des séquences auto-complémentaires interrompues, une séquence auto-complémentaire étant interrompue par une séquence de bras transversal formant deux tiges-boucles longitudinalement symétriques, opposées, et l'autre des séquences auto-complémentaires étant interrompue par une séquence de bras transversal tronquée. L'invention concerne en outre des procédés d'administration de l'acide nucléique à une cellule.
Patent EP-3501232-A1 (EP)
Inventor: VELEV GENADI
IPC: H04W76/00
Filed: 2017-08-18
Abstract: La présente invention concerne un équipement utilisateur (UE) comprenant : un émetteur, configuré de manière à émettre au moins un identifiant de session (ID) de l'unité de données de protocole (PDU), chaque identifiant indiquant une session PDU que l'UE doit utiliser dans un message de demande de service de strate de non accès (NAS) à une fonction de gestion de mobilité (MMF) par l'intermédiaire d'un nœud de réseau d'accès (AN) lorsque l'UE comporte des données utilisateur à envoyer.
Patent EP-3682381-A1 (EP)
Inventor: FOWLER AUSTIN GREIG
IPC: G06N99/00
Filed: 2017-09-12
Abstract: A quantum error correction method including correcting a stream of syndrome measurements produced by a quantum computer comprises receiving a layered representation of error propagation through quantum error detection circuits, the layered representation comprises a plurality of line circuit layers that each represent a probability of local detection events in a quantum computer associated with one or more potential error processes in the execution of a quantum algorithm; during execution of the quantum algorithm: receiving one or more syndrome measurements from quantum error detection circuits; converting the syndrome measurements into detection events written to an array that represents a patch of quantum error correction circuits at a sequence of steps in the quantum algorithm; determining one or more errors in the execution of the quantum algorithm from the detection events in dependence upon the stored line circuit layers; and causing correction of the syndrome measurements based on the determined errors.
Patent EP-3512606-A1 (EP)
Inventor: ANDRE-FREI VALÉRIE
IPC: A61Q17/00
Filed: 2017-09-14
Abstract: The invention concerns the cosmetic or nutraceutical use of a  Saccharomyces cerevisiae  extract by topical or oral administration, in order to increase the ratio of the content of  Staphylococcus epidermidis  relative to the content of  Staphylococcus aureus  in the skin and/or mucous membranes and/or to increase the commensal and/or mucosal microbial flora. The present invention also concerns an  S. cerevisiae  extract for the pharmaceutical, and preferably dermatological, use of same, or for the use of same in the treatment or prevention of pathological conditions involving a reduction in the content of beneficial cutaneous and/or mucosal commensal microorganisms and/or an increase in the content of pathogenic microorganisms.
Patent EP-3441592-A1 (EP)
Inventor: KASHIWA Koki
IPC: F01M1/10
Filed: 2017-03-29
Abstract: An engine device includes a cylinder block 6 having one side portion to which a flywheel that is rotated integrally with a crankshaft 5 is disposed. The engine device is provided with a starter 20 that transmits a rotational force to the flywheel at a time of engine start. A flywheel housing 7, which accommodates the flywheel and includes a starter attachment pedestal for attaching the starter 20, is attached to the one side portion of the cylinder block 6. The starter 20 is disposed inner of the engine than a portion of the flywheel housing 7, the portion being located outermost in the engine with respect to a direction that is perpendicular to a direction along a crankshaft center 300 and that is parallel to a cylinder head joining surface 341 of the cylinder block 6.
Patent EP-3526832-A1 (EP)
Inventor: FEES HEINER
IPC: H01M50/244
Filed: 2017-10-13
Abstract: An embodiment is directed to a multi-layer contact plate configured to establish electrical bonds to battery cells in a battery module. The multi-layer contact plate includes two or more primary conductive layers (e.g., Al, Cu, etc.), and a cell terminal connection layer (e.g., steel, Al, Cu, etc.) that is joined with, and sandwiched by, the two or more primary conductive layers. A portion of the cell terminal connection layer is configured to form a set of bonding connectors (e.g., bonding ribbons) to provide a direct electrical bond between the multi-layer contact plate and terminals (e.g., positive terminals, negative terminals, or a combination thereof) of at least one group of battery cells (e.g., a single group of battery cells, two groups of battery cells that are connected in series, etc.).
Patent EP-3545242-A1 (EP)
Inventor: PRINS JAN
IPC: F25B41/00
Filed: 2017-11-15
Abstract: La présente invention concerne un procédé de commande d'un système de compression de vapeur (1). Un dysfonctionnement d'une soupape de dérivation de gaz (8) est enregistré. Un degré d'ouverture réel de la soupape de dérivation de gaz (8) est obtenu, et un degré d'ouverture cible de la soupape de dérivation de gaz (8) est obtenu, sur la base d'un ou de plusieurs paramètres de commande du système de compression de vapeur (1). Le degré d'ouverture réel est comparé au degré d'ouverture cible, et le système de compression de vapeur (1) est commandé sur la base de cette comparaison, et afin de faire correspondre un flux massique de réfrigérant gazeux à travers la soupape de dérivation de gaz (8) au degré d'ouverture réel de la soupape de dérivation de gaz (8).
Patent EP-3460819-A1 (EP)
Inventor: OKADA TAKAHIRO
IPC: H01H19/02
Filed: 2017-05-16
Abstract: A rotary switch device includes a terminal base to which a center portion contact and a fixed contact member are fixed, a movable contact member which includes a contact protrusion part being in pressure contact with the center portion contact at one end and a contact surface with the fixed contact member at the other end, and is operated to rotate around the center portion contact so as to short-circuit between the center portion contact and the fixed contact member at a conductive rotation position, and a support portion which is formed in the terminal base and supports an edge corner portion along a rotation direction when the contact surface of the movable contact member is operated to rotate. The movable contact member slides on the support portion with the edge corner portion as a sliding contact portion and moves to the conductive rotation position where the contact surface is in contact with the fixed contact member.
Patent EP-3464559-A1 (EP)
Inventor: LIEW FUNGMIN
IPC: C12N9/02
Filed: 2017-05-12
Abstract: L'invention concerne une bactérie non naturelle ayant une activité réduite ou éliminée d'une enzyme qui catalyse la réaction définie par EC 1.2.7.5, telle que l'aldéhyde/ferrédoxine oxydoréductase (AOR) En option, la bactérie a également une activité réduite ou éliminée d'une enzyme qui catalyse la réaction définie par EC 1.2.1.10 et/ou EC 1.1.1.1, telle que l'aldéhyde déshydrogénase, l'alcool déshydrogénase, ou l'aldéhyde/alcool déshydrogénase bifonctionnelle. L'invention concerne en outre des procédés de production de produits par culture de la bactérie en présence d'un substrat gazeux contenant un ou plusieurs des éléments suivants : CO, CO2 et H2
Patent EP-3458061-A1 (EP)
Inventor: ZHANG YAN
IPC: A61K31/485
Filed: 2017-05-16
Abstract: Analogues of 6 α/β-naltrexamine (NAQ) are provided. The analogues are selective, reversible antagonists of the mu opioid receptor (MOR) that exhibit good blood brain barrier penetration. The compounds are used in the treatment of opioid addiction and other diseases and conditions, including for the treatment of pain.
Patent EP-3467030-A1 (EP)
Inventor: OGAWA NORIYOSHI
IPC: G02B1/04
Filed: 2017-04-07
Abstract: The present invention addresses the problem of providing an optical use polycarbonate resin composition which exhibits good fluidity, has a high refractive index, is inexpensive and exhibits impact resistance. This problem can be solved by an optical use polycarbonate resin composition that contains a polycarbonate resin (A) which contains a constituent unit represented by formula (1) and has an intrinsic viscosity of 0.320-0.630 dL/g, and polycarbonate resin (B) which contains a constituent unit represented by formula (2) and has an intrinsic viscosity of 0.320-0.600 dL/g, wherein the polycarbonate resin that contains a constituent unit represented by formula (2) is contained at a proportion of 45-75 mass%.
Patent EP-3538178-A1 (EP)
Inventor: BJERREGAARD HENRIK BORK
IPC: A61M3/02
Filed: 2017-11-02
Abstract: A nozzle for an enema device, a packaging including the nozzle, and an enema device comprising the nozzle. A funnel-shaped nozzle (1) of the kind comprising a flared proximal part (2) that tapers into a tubular distal part (3), has at least a part of an exterior annular wall (3a) of the tubular distal part (3) provided with a hydrophilic coating (4) to provide reduced friction during use of the nozzle (1) during performing an enema.
Patent EP-3535423-A1 (EP)
Inventor: PATEL SHASHANKKUMAR J
IPC: C12Q1/6886
Filed: 2017-11-07
Abstract: Disclosed are methods of selecting a therapy for a cancer patient and methods of treating cancer in the patient. The methods comprise detecting a mutation in one or more genes in a cancer cell from the patient, wherein the one or more genes is selected from the group consisting of  PTCD2, TWF1, DEFB134, BBS1, SOX10, APLNR, CD58, COL17A1, CRKL, hsa-mir-101-2, hsa-mir-548s, MAD2L1, MLANA, PSMB5, RNPS1, RPL10A, RPL23, SRP54, TAF3, TAP1, TAP2, TAPBP, TBXAS1, GMIP, OTOA, LAIR1, CLEC1, GPSM3, TRAF1, JAK2, TAPBPL, ICAM1, LILRA1, LILRA3, STAT1, and HLA-F . Also disclosed are methods of screening for one or more genes, the mutation of which confers resistance to T cell-mediated cytolytic activity.
Patent EP-3544725-A1 (EP)
Inventor: PREWER ANDREW
IPC: B01J19/00
Filed: 2017-11-20
Abstract: This invention relates to an elongate solid phase body suitable for performing solid phase synthesis. The solid phase body comprises a plurality of enclosures formed of a material comprising a chemically inert mesh and, within each enclosure, a plurality of solid phase beads.
Patent EP-3545427-A1 (EP)
Inventor: ANBAZHAGAN VIKRAM SATHYANARAYANA
IPC: G06F17/28
Filed: 2017-11-22
Abstract: A natural language understanding model is trained using respective natural language example inputs corresponding to a plurality of applications. A determination is made as to whether a value of a first parameter of a first application is to be obtained using a natural language interaction. Using the natural language understanding model, at least a portion of the first application is generated.
Patent EP-3548266-A1 (EP)
Inventor: ARCHER PAUL
IPC: A43B13/12
Filed: 2017-12-05
Abstract: Joining a bottom unit, such as an athletic shoe sole, with an upper is achieved with an over molding process. A midsole core may be formed with a direct attach to an underfoot portion of the upper. The forming of the midsole core may be achieved with open cast molding or injection molding, for example. A shell may encapsulate the midsole core and also mechanically engage with the upper to further join the bottom unit with the upper. The shell and the midsole core may be formed from an elastomeric polymer such as polyurethane, thermoplastic polyurethane, ethyl-vinyl acetate, and/or silicone-based materials.
Patent EP-3554479-A1 (EP)
Inventor: BRODKORB ANDRE
IPC: A61K9/50
Filed: 2017-12-19
Abstract: A method for producing beads comprising an active component encased therein, the method comprising providing a solution comprising heat-treated milk protein product, alginate and an active component. A microbead preparation is also provided. A macrobead preparation is also provided.
Patent EP-3559686-A1 (EP)
Title: Shunt thermocouple
Inventor: MAKINSON DAVID NELSON
IPC: G01R19/32
Filed: 2017-12-19
Abstract: A thermocouple device includes a shared conductor for a shunt measurement and a thermocouple measurement. For example, the thermocouple device may include a shared conductor that provides a signal to both calculate current of a shunt and calculate a temperature of the shunt. The thermocouple device may provide an efficient structure that accurately calculates current and temperature. In addition, the thermocouple device may use the temperature of the shunt to detect when a conductive path is overheating. The temperature of the shunt may also be used for other purposes.
Patent EP-3490545-A1 (EP)
Title: Méthodes de traitement médical avec des inhibiteurs du canal sur1-trpm4
Inventor: JACOBSON SVEN
IPC: A61K31/64
Filed: 2017-07-28
Abstract: Procédé de traitement ou de prévention de résultats négatifs associés à l'administration d'un activateur tissulaire du plasminogène (tPA), aux effets secondaires liés à un œdème cérébral, à un œdème cérébral associé à une radiothérapie, ou aux céphalées migraineuses par administration d'une quantité efficace d'un inhibiteur du canal SUR1-TRPM4, tel que le glyburide, et facultativement la co-administration d'un second agent thérapeutiquement actif, à un sujet en ayant besoin. Les résultats négatifs associés au tPA comprennent une hémorragie cérébrale, un œdème cérébral, une déficience physique ou la mort. L'administration d'inhibiteurs du canal SUR1-TRPM4 se produit avant la radiothérapie, pendant la radiothérapie, après la radiothérapie, ou des combinaisons de celles-ci. L'inhibiteur du canal SUR1-TRPM4 est administré avant l'excision chirurgicale d'une tumeur cérébrale, une thérapie CAR-T, ou l'administration de flutarabine. En variante, ou en plus, l'inhibiteur du canal SUR1-TRPM4 est administré avant l'apparition des effets secondaires liés à un œdème cérébral.
Patent EP-3496247-A1 (EP)
Inventor: UEDA TOMOYA
IPC: H02K1/14
Filed: 2017-08-04
Abstract: A stator core 220 includes an annular core back portion 221; and a plurality of teeth 222. The plurality of teeth 222 extend radially from the core back portion 221 to a rotor magnet having a plurality of magnets. A ratio of the number of slots, which is the number of the plurality of teeth 222, to the number of poles, which is the number of magnets of the rotor magnet, is 3:4. In the stator core 220, a slot open ratio which is a ratio of a slot open angle θ2 between two adjacent teeth 222 in a peripheral direction to an angle θ1 between center lines of the two teeth 222 is 0.5 or more. When, in the rotor magnet, a ratio of a peripheral angle of one magnet to an angle between center positions of two adjacent magnets in the peripheral direction is set as a magnet ratio, a ratio of the slot open ratio to the magnet ratio is 0.6 to 0.7.
Patent EP-3444866-A1 (EP)
Inventor: YOON SU-JIN
IPC: H01M50/489
Filed: 2017-08-09
Abstract: Disclosed are a separator and an electrochemical device including the same. The separator includes: a porous polymer substrate having a plurality of pores; a separator base including a porous coating layer formed on at least one surface of the porous polymer substrate, said porous coating layer comprising a plurality of inorganic particles and a binder polymer disposed partially or totally on the surface of the inorganic particles to connect and fix the inorganic particles with each other; and an adhesive porous layer formed on at least one surface of the separator base, said adhesive porous layer comprising an adhesive resin which shows adhesive property through heating at a temperature lower than a melting point of the porous polymer substrate, wherein the adhesive porous layer is provided with a porous structure formed by phase separation caused by an evaporation rate of a solvent and that of a non-solvent, when applying and drying a coating composition including the adhesive resin, the solvent and the non-solvent on at least one surface of the separator base.
Patent EP-3507721-A1 (EP)
Inventor: Paterson Gordon Scott
IPC: G06F3/0481
Filed: 2017-02-28
Abstract: Methods, systems and computer program products for organizing and displaying in real-time data related to a plurality of documents. A plurality of documents and a plurality of entity identifiers are stored in a relational database storage. Each entity identifier has an entity type selected from a plurality of entity types. A plurality of entity associations between the plurality of entity identifiers and the plurality of documents are stored in a non-relational database storage. Each entity association defines a relationship between one or more entity identifiers and a selected document in the plurality of documents. A plurality of file icons are displayed in a display interface. The plurality of file icons includes active icons corresponding to a election of the plurality of documents where the selection is determined by querying he non-relational database storage using at least one currently-selected entity identifier.
Patent EP-3506913-A1 (EP)
Inventor: LI ZHEN
IPC: C12N15/87
Filed: 2017-03-07
Abstract: Described are novel targeting ligands that may be linked to compounds, such therapeutic compounds that are useful in directing the compounds to the in vivo target. The targeting ligands disclosed herein can serve to target expression-inhibiting oligomeric compounds, such as RNAi agents, to liver cells to modulate gene expression. The targeting ligands disclosed herein, when conjugated to a therapeutic compound, may be used in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Compositions including the targeting ligands disclosed herein when linked to expression- inhibiting oligomeric compounds are capable of mediating expression of target nucleic acid sequences in liver cells, such as hepatocytes, which may be useful in the treatment of diseases or conditions that respond to inhibition of gene expression or activity in a cell, tissue, or organism.
Patent EP-3510309-A1 (EP)
Inventor: TIFFANY HENRY D
IPC: F16K15/06
Filed: 2017-08-06
Abstract: A sanitary high pressure valve assembly is provided. The valve assembly includes an inlet adaptor for admitting pressurized gas into a sanitary central passageway for release into a storage vessel containing granular material for the purpose of aiding flow of the granular material from the storage vessel. The valve assembly also includes an isolation chamber for housing serviceable parts that are isolated from the sanitary central passageway.
Patent EP-3454066-A1 (EP)
Inventor: KIM TAE YOUN
IPC: G01R1/20
Filed: 2017-09-20
Abstract: The present invention relates to a device and a method for diagnosing a switch using voltage distribution, and more particularly, to a device and a method for diagnosing a switch using voltage distribution, which connect one or more resistors connected in series with the switch in parallel and calculate voltage applied to one resistor among one or more resistors by using the voltage distribution to diagnose a state of the switch based on the calculated voltage, in order to diagnose the state of the switch positioned on a cathode power supply line connecting a battery and a load.